India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Ministry of Commerce and Industry
Read More
US Tariff Action Could Backfire and Hurt American Healthcare More than India: Experts
India’s pharmaceutical sector has responded strongly to US President Donald Trump’s recent announcement of a 25% tariff on all Indian…
MedTech Industry Welcomes India-UK FTA but Urges Vigil on Trade Flows
The formal announcement of the Free Trade Agreement (FTA) between India and the United Kingdom has been met with optimism…
Push for Regulation Grows as Chinese Devices Dominate India’s MedTech Market
Indian medical device manufacturers have raised alarms over the increasing influx of Chinese-made equipment in the country’s healthcare ecosystem. The…
US Presses India to Drop Tariffs, Ease Medical Device Price Controls Ahead of Trade Deal
As India and the United States push to finalize an interim trade agreement before new US tariffs come into effect…